Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
90.44
-0.65 (-0.71%)
Feb 21, 2025, 4:00 PM EST - Market closed
Amedisys Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Amedisys stock have an average target of 100.75, with a low estimate of 100 and a high estimate of 101. The average target predicts an increase of 11.40% from the current stock price of 90.44.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amedisys stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +11.68% | Feb 12, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $101 | Strong Buy → Hold | Downgrades | $101 | +11.68% | Jul 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +11.68% | Jul 25, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +11.68% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
2.40B
from 2.24B
Increased by 7.14%
Revenue Next Year
2.52B
from 2.40B
Increased by 5.26%
EPS This Year
4.47
from -0.30
EPS Next Year
4.99
from 4.47
Increased by 11.66%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.5B | 2.6B | 2.8B | |
| Avg | 2.4B | 2.5B | 2.7B | |
| Low | 2.3B | 2.4B | 2.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 10.8% | 10.1% | 12.5% | |
| Avg | 7.1% | 5.3% | 6.4% | |
| Low | 2.7% | -0.2% | -1.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.73 | 5.46 | 5.63 | |
| Avg | 4.47 | 4.99 | 5.26 | |
| Low | 4.04 | 4.49 | 4.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 22.2% | 12.8% | |
| Avg | - | 11.7% | 5.5% | |
| Low | - | 0.5% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.